ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global OTC and DTC Infectious Disease Diagnostic Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-8R14626
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global OTC and DTC Infectious Disease Diagnostic Market Research Report 2023
BUY CHAPTERS

Global OTC and DTC Infectious Disease Diagnostic Market Research Report 2025

Code: QYRE-Auto-8R14626
Report
May 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott
Bio-Rad Laboratories Inc
BD
Bosch Healthcare Solutions GmbH
Danaher
ThermoFisher Scientific
Siemens AG
Roche Holding AG
Hologic Inc
Qiagen NV
Cardinal Health
Quest Diagnostics Incorporated
Ador Diagnostics
Akonni Biosystems, Inc.
Alveo Technologies
binx health, inc.
bioMérieux
Curetis
Sysmex Europe GmbH
DiaSorin

OTC and DTC Infectious Disease Diagnostic Market Size

The global market for OTC and DTC Infectious Disease Diagnostic was valued at US$ 5438 million in the year 2024 and is projected to reach a revised size of US$ 8619 million by 2031, growing at a CAGR of 6.9% during the forecast period.

OTC and DTC Infectious Disease Diagnostic Market

OTC and DTC Infectious Disease Diagnostic Market

In the manufacture and quality control of medicinal products, compliance with the GMP rules is the decisive aspect for manufacturing high-quality products. For this reason, every staff member in the pharmaceutical industry has to be familiar with the basic GMP requirements
The global OTC (Over-the-Counter) and DTC (Direct-to-Consumer) infectious disease diagnostic market refers to the market for diagnostic tests that can be purchased without a prescription or directly by consumers for the detection of infectious diseases. These diagnostic tests are designed to be user-friendly, affordable, and accessible, allowing individuals to self-diagnose and monitor their health conveniently at home.
Here are some key factors influencing the growth of the global OTC and DTC infectious disease diagnostic market:
Increasing consumer awareness and demand: Over the years, there has been a significant increase in consumer awareness regarding infectious diseases and the importance of early detection. Individuals are seeking convenience and control over their healthcare, leading to a growing demand for OTC and DTC diagnostic tests. These tests allow individuals to quickly and easily screen for infectious diseases from the comfort of their homes, without the need for a doctor’s visit.
Advancements in technology: Technological advancements have paved the way for the development of accurate and reliable OTC and DTC diagnostic tests for infectious diseases. Rapid diagnostic tests, including lateral flow immunoassays and molecular-based tests, have become more sensitive, specific, and user-friendly. The integration of digital health technologies, such as smartphone apps and connectivity options, further enhances the usability and accessibility of these tests.
COVID-19 pandemic: The ongoing COVID-19 pandemic has significantly accelerated the adoption of OTC and DTC infectious disease diagnostic tests. The need for widespread testing, contact tracing, and monitoring of COVID-19 cases has created a demand for accessible and affordable testing options. The availability of COVID-19 self-testing kits and at-home PCR testing has showcased the potential of OTC and DTC testing, driving awareness and acceptance among consumers.
Regulatory landscape: Regulatory agencies have played a crucial role in shaping the OTC and DTC infectious disease diagnostic market. Clear guidelines and regulatory frameworks for the development, marketing, and sale of these tests ensure their safety, accuracy, and performance. Regulatory approvals and certifications provide assurance to consumers, paving the way for increased adoption of these tests.
Market players and collaborations: Various companies and startups are actively investing in the development and commercialization of OTC and DTC infectious disease diagnostic tests. These companies collaborate with technology providers, pharmaceutical companies, and telehealth platforms to expand their product offerings and reach a wider consumer base. Partnerships with retail pharmacies, e-commerce platforms, and telemedicine providers also facilitate the distribution and accessibility of these tests.
The global OTC and DTC infectious disease diagnostic market can be segmented based on disease type, test type, end-user, and geography. Disease types may include respiratory infections, sexually transmitted infections, gastrointestinal infections, and others. Test types can include rapid antigen tests, molecular tests, serological tests, and others. End-users may include households, pharmacies, online retailers, and others.
Geographically, the market can be divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market dynamics and consumer preferences may vary across these regions.
In summary, the global OTC and DTC infectious disease diagnostic market is driven by increasing consumer awareness, technological advancements, the impact of the COVID-19 pandemic, regulatory landscape, and collaborations among market players. The market is expected to witness significant growth as more individuals seek accessible and convenient options for self-diagnosis and monitoring of infectious diseases.The global OTC (Over-the-Counter) and DTC (Direct-to-Consumer) infectious disease diagnostic market refers to the market for diagnostic tests that can be purchased without a prescription or directly by consumers for the detection of infectious diseases. These diagnostic tests are designed to be user-friendly, affordable, and accessible, allowing individuals to self-diagnose and monitor their health conveniently at home.
Here are some key factors influencing the growth of the global OTC and DTC infectious disease diagnostic market:
Increasing consumer awareness and demand: Over the years, there has been a significant increase in consumer awareness regarding infectious diseases and the importance of early detection. Individuals are seeking convenience and control over their healthcare, leading to a growing demand for OTC and DTC diagnostic tests. These tests allow individuals to quickly and easily screen for infectious diseases from the comfort of their homes, without the need for a doctor’s visit.
Advancements in technology: Technological advancements have paved the way for the development of accurate and reliable OTC and DTC diagnostic tests for infectious diseases. Rapid diagnostic tests, including lateral flow immunoassays and molecular-based tests, have become more sensitive, specific, and user-friendly. The integration of digital health technologies, such as smartphone apps and connectivity options, further enhances the usability and accessibility of these tests.
COVID-19 pandemic: The ongoing COVID-19 pandemic has significantly accelerated the adoption of OTC and DTC infectious disease diagnostic tests. The need for widespread testing, contact tracing, and monitoring of COVID-19 cases has created a demand for accessible and affordable testing options. The availability of COVID-19 self-testing kits and at-home PCR testing has showcased the potential of OTC and DTC testing, driving awareness and acceptance among consumers.
Regulatory landscape: Regulatory agencies have played a crucial role in shaping the OTC and DTC infectious disease diagnostic market. Clear guidelines and regulatory frameworks for the development, marketing, and sale of these tests ensure their safety, accuracy, and performance. Regulatory approvals and certifications provide assurance to consumers, paving the way for increased adoption of these tests.
Market players and collaborations: Various companies and startups are actively investing in the development and commercialization of OTC and DTC infectious disease diagnostic tests. These companies collaborate with technology providers, pharmaceutical companies, and telehealth platforms to expand their product offerings and reach a wider consumer base. Partnerships with retail pharmacies, e-commerce platforms, and telemedicine providers also facilitate the distribution and accessibility of these tests.
The global OTC and DTC infectious disease diagnostic market can be segmented based on disease type, test type, end-user, and geography. Disease types may include respiratory infections, sexually transmitted infections, gastrointestinal infections, and others. Test types can include rapid antigen tests, molecular tests, serological tests, and others. End-users may include households, pharmacies, online retailers, and others.
Geographically, the market can be divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market dynamics and consumer preferences may vary across these regions.
In summary, the global OTC and DTC infectious disease diagnostic market is driven by increasing consumer awareness, technological advancements, the impact of the COVID-19 pandemic, regulatory landscape, and collaborations among market players. The market is expected to witness significant growth as more individuals seek accessible and convenient options for self-diagnosis and monitoring of infectious diseases.
This report aims to provide a comprehensive presentation of the global market for OTC and DTC Infectious Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC and DTC Infectious Disease Diagnostic.
The OTC and DTC Infectious Disease Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global OTC and DTC Infectious Disease Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC and DTC Infectious Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of OTC and DTC Infectious Disease Diagnostic Market Report

Report Metric Details
Report Name OTC and DTC Infectious Disease Diagnostic Market
Accounted market size in year US$ 5438 million
Forecasted market size in 2031 US$ 8619 million
CAGR 6.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Bio-Rad Laboratories Inc, BD, Bosch Healthcare Solutions GmbH, Danaher, ThermoFisher Scientific, Siemens AG, Roche Holding AG, Hologic, Inc., Qiagen, Cardinal Health, Quest Diagnostics Incorporated, Ador Diagnostics, Akonni Biosystems, Inc., Alveo Technologies, Binx Health Inc., bioMérieux, Inc., Curetis, Sysmex Europe GmbH, Diasorin S.p.A
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of OTC and DTC Infectious Disease Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is OTC and DTC Infectious Disease Diagnostic Market growing?

Ans: The OTC and DTC Infectious Disease Diagnostic Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the OTC and DTC Infectious Disease Diagnostic Market size in 2031?

Ans: The OTC and DTC Infectious Disease Diagnostic Market size in 2031 will be US$ 8619 million.

Who are the main players in the OTC and DTC Infectious Disease Diagnostic Market report?

Ans: The main players in the OTC and DTC Infectious Disease Diagnostic Market are Abbott, Bio-Rad Laboratories Inc, BD, Bosch Healthcare Solutions GmbH, Danaher, ThermoFisher Scientific, Siemens AG, Roche Holding AG, Hologic, Inc., Qiagen, Cardinal Health, Quest Diagnostics Incorporated, Ador Diagnostics, Akonni Biosystems, Inc., Alveo Technologies, Binx Health Inc., bioMérieux, Inc., Curetis, Sysmex Europe GmbH, Diasorin S.p.A

What are the Application segmentation covered in the OTC and DTC Infectious Disease Diagnostic Market report?

Ans: The Applications covered in the OTC and DTC Infectious Disease Diagnostic Market report are Diagnostic Laboratories, Hospitals and Clinics, Academic Research Institutes, Others

What are the Type segmentation covered in the OTC and DTC Infectious Disease Diagnostic Market report?

Ans: The Types covered in the OTC and DTC Infectious Disease Diagnostic Market report are PCR, Immunodiagnostics, Clinical Microbiology, INAAT, DNA Sequencing and NGS, DNA Microarrays, Others

Recommended Reports

Infectious Disease Diagnostics

Rapid/Home Diagnostics

POC & OTC Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 Immunodiagnostics
1.2.4 Clinical Microbiology
1.2.5 INAAT
1.2.6 DNA Sequencing and NGS
1.2.7 DNA Microarrays
1.2.8 Others
1.3 Market by Application
1.3.1 Global OTC and DTC Infectious Disease Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals and Clinics
1.3.4 Academic Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC and DTC Infectious Disease Diagnostic Market Perspective (2020-2031)
2.2 Global OTC and DTC Infectious Disease Diagnostic Growth Trends by Region
2.2.1 Global OTC and DTC Infectious Disease Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 OTC and DTC Infectious Disease Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 OTC and DTC Infectious Disease Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 OTC and DTC Infectious Disease Diagnostic Market Dynamics
2.3.1 OTC and DTC Infectious Disease Diagnostic Industry Trends
2.3.2 OTC and DTC Infectious Disease Diagnostic Market Drivers
2.3.3 OTC and DTC Infectious Disease Diagnostic Market Challenges
2.3.4 OTC and DTC Infectious Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC and DTC Infectious Disease Diagnostic Players by Revenue
3.1.1 Global Top OTC and DTC Infectious Disease Diagnostic Players by Revenue (2020-2025)
3.1.2 Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global OTC and DTC Infectious Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by OTC and DTC Infectious Disease Diagnostic Revenue
3.4 Global OTC and DTC Infectious Disease Diagnostic Market Concentration Ratio
3.4.1 Global OTC and DTC Infectious Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC and DTC Infectious Disease Diagnostic Revenue in 2024
3.5 Global Key Players of OTC and DTC Infectious Disease Diagnostic Head office and Area Served
3.6 Global Key Players of OTC and DTC Infectious Disease Diagnostic, Product and Application
3.7 Global Key Players of OTC and DTC Infectious Disease Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC and DTC Infectious Disease Diagnostic Breakdown Data by Type
4.1 Global OTC and DTC Infectious Disease Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global OTC and DTC Infectious Disease Diagnostic Forecasted Market Size by Type (2026-2031)
5 OTC and DTC Infectious Disease Diagnostic Breakdown Data by Application
5.1 Global OTC and DTC Infectious Disease Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global OTC and DTC Infectious Disease Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America OTC and DTC Infectious Disease Diagnostic Market Size (2020-2031)
6.2 North America OTC and DTC Infectious Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025)
6.4 North America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC and DTC Infectious Disease Diagnostic Market Size (2020-2031)
7.2 Europe OTC and DTC Infectious Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025)
7.4 Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC and DTC Infectious Disease Diagnostic Market Size (2020-2031)
9.2 Latin America OTC and DTC Infectious Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025)
9.4 Latin America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott OTC and DTC Infectious Disease Diagnostic Introduction
11.1.4 Abbott Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Bio-Rad Laboratories Inc
11.2.1 Bio-Rad Laboratories Inc Company Details
11.2.2 Bio-Rad Laboratories Inc Business Overview
11.2.3 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Introduction
11.2.4 Bio-Rad Laboratories Inc Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.2.5 Bio-Rad Laboratories Inc Recent Development
11.3 BD
11.3.1 BD Company Details
11.3.2 BD Business Overview
11.3.3 BD OTC and DTC Infectious Disease Diagnostic Introduction
11.3.4 BD Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.3.5 BD Recent Development
11.4 Bosch Healthcare Solutions GmbH
11.4.1 Bosch Healthcare Solutions GmbH Company Details
11.4.2 Bosch Healthcare Solutions GmbH Business Overview
11.4.3 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Introduction
11.4.4 Bosch Healthcare Solutions GmbH Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.4.5 Bosch Healthcare Solutions GmbH Recent Development
11.5 Danaher
11.5.1 Danaher Company Details
11.5.2 Danaher Business Overview
11.5.3 Danaher OTC and DTC Infectious Disease Diagnostic Introduction
11.5.4 Danaher Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.5.5 Danaher Recent Development
11.6 ThermoFisher Scientific
11.6.1 ThermoFisher Scientific Company Details
11.6.2 ThermoFisher Scientific Business Overview
11.6.3 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Introduction
11.6.4 ThermoFisher Scientific Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.6.5 ThermoFisher Scientific Recent Development
11.7 Siemens AG
11.7.1 Siemens AG Company Details
11.7.2 Siemens AG Business Overview
11.7.3 Siemens AG OTC and DTC Infectious Disease Diagnostic Introduction
11.7.4 Siemens AG Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.7.5 Siemens AG Recent Development
11.8 Roche Holding AG
11.8.1 Roche Holding AG Company Details
11.8.2 Roche Holding AG Business Overview
11.8.3 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Introduction
11.8.4 Roche Holding AG Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.8.5 Roche Holding AG Recent Development
11.9 Hologic, Inc.
11.9.1 Hologic, Inc. Company Details
11.9.2 Hologic, Inc. Business Overview
11.9.3 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Introduction
11.9.4 Hologic, Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.9.5 Hologic, Inc. Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen OTC and DTC Infectious Disease Diagnostic Introduction
11.10.4 Qiagen Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.10.5 Qiagen Recent Development
11.11 Cardinal Health
11.11.1 Cardinal Health Company Details
11.11.2 Cardinal Health Business Overview
11.11.3 Cardinal Health OTC and DTC Infectious Disease Diagnostic Introduction
11.11.4 Cardinal Health Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.11.5 Cardinal Health Recent Development
11.12 Quest Diagnostics Incorporated
11.12.1 Quest Diagnostics Incorporated Company Details
11.12.2 Quest Diagnostics Incorporated Business Overview
11.12.3 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Introduction
11.12.4 Quest Diagnostics Incorporated Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.12.5 Quest Diagnostics Incorporated Recent Development
11.13 Ador Diagnostics
11.13.1 Ador Diagnostics Company Details
11.13.2 Ador Diagnostics Business Overview
11.13.3 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Introduction
11.13.4 Ador Diagnostics Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.13.5 Ador Diagnostics Recent Development
11.14 Akonni Biosystems, Inc.
11.14.1 Akonni Biosystems, Inc. Company Details
11.14.2 Akonni Biosystems, Inc. Business Overview
11.14.3 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Introduction
11.14.4 Akonni Biosystems, Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.14.5 Akonni Biosystems, Inc. Recent Development
11.15 Alveo Technologies
11.15.1 Alveo Technologies Company Details
11.15.2 Alveo Technologies Business Overview
11.15.3 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Introduction
11.15.4 Alveo Technologies Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.15.5 Alveo Technologies Recent Development
11.16 Binx Health Inc.
11.16.1 Binx Health Inc. Company Details
11.16.2 Binx Health Inc. Business Overview
11.16.3 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Introduction
11.16.4 Binx Health Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.16.5 Binx Health Inc. Recent Development
11.17 bioMérieux, Inc.
11.17.1 bioMérieux, Inc. Company Details
11.17.2 bioMérieux, Inc. Business Overview
11.17.3 bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Introduction
11.17.4 bioMérieux, Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.17.5 bioMérieux, Inc. Recent Development
11.18 Curetis
11.18.1 Curetis Company Details
11.18.2 Curetis Business Overview
11.18.3 Curetis OTC and DTC Infectious Disease Diagnostic Introduction
11.18.4 Curetis Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.18.5 Curetis Recent Development
11.19 Sysmex Europe GmbH
11.19.1 Sysmex Europe GmbH Company Details
11.19.2 Sysmex Europe GmbH Business Overview
11.19.3 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Introduction
11.19.4 Sysmex Europe GmbH Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.19.5 Sysmex Europe GmbH Recent Development
11.20 Diasorin S.p.A
11.20.1 Diasorin S.p.A Company Details
11.20.2 Diasorin S.p.A Business Overview
11.20.3 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Introduction
11.20.4 Diasorin S.p.A Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
11.20.5 Diasorin S.p.A Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Abbott
Bio-Rad Laboratories Inc
BD
Bosch Healthcare Solutions GmbH
Danaher
ThermoFisher Scientific
Siemens AG
Roche Holding AG
Hologic Inc
Qiagen NV
Cardinal Health
Quest Diagnostics Incorporated
Ador Diagnostics
Akonni Biosystems, Inc.
Alveo Technologies
binx health, inc.
bioMérieux
Curetis
Sysmex Europe GmbH
DiaSorin
List of Tables
 Table 1. Global OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of PCR
 Table 3. Key Players of Immunodiagnostics
 Table 4. Key Players of Clinical Microbiology
 Table 5. Key Players of INAAT
 Table 6. Key Players of DNA Sequencing and NGS
 Table 7. Key Players of DNA Microarrays
 Table 8. Key Players of Others
 Table 9. Global OTC and DTC Infectious Disease Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global OTC and DTC Infectious Disease Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global OTC and DTC Infectious Disease Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global OTC and DTC Infectious Disease Diagnostic Market Share by Region (2020-2025)
 Table 13. Global OTC and DTC Infectious Disease Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global OTC and DTC Infectious Disease Diagnostic Market Share by Region (2026-2031)
 Table 15. OTC and DTC Infectious Disease Diagnostic Market Trends
 Table 16. OTC and DTC Infectious Disease Diagnostic Market Drivers
 Table 17. OTC and DTC Infectious Disease Diagnostic Market Challenges
 Table 18. OTC and DTC Infectious Disease Diagnostic Market Restraints
 Table 19. Global OTC and DTC Infectious Disease Diagnostic Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global OTC and DTC Infectious Disease Diagnostic Market Share by Players (2020-2025)
 Table 21. Global Top OTC and DTC Infectious Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC and DTC Infectious Disease Diagnostic as of 2024)
 Table 22. Ranking of Global Top OTC and DTC Infectious Disease Diagnostic Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by OTC and DTC Infectious Disease Diagnostic Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of OTC and DTC Infectious Disease Diagnostic, Headquarters and Area Served
 Table 25. Global Key Players of OTC and DTC Infectious Disease Diagnostic, Product and Application
 Table 26. Global Key Players of OTC and DTC Infectious Disease Diagnostic, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global OTC and DTC Infectious Disease Diagnostic Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Type (2020-2025)
 Table 30. Global OTC and DTC Infectious Disease Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Type (2026-2031)
 Table 32. Global OTC and DTC Infectious Disease Diagnostic Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Application (2020-2025)
 Table 34. Global OTC and DTC Infectious Disease Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share by Application (2026-2031)
 Table 36. North America OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe OTC and DTC Infectious Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America OTC and DTC Infectious Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Abbott Company Details
 Table 52. Abbott Business Overview
 Table 53. Abbott OTC and DTC Infectious Disease Diagnostic Product
 Table 54. Abbott Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 55. Abbott Recent Development
 Table 56. Bio-Rad Laboratories Inc Company Details
 Table 57. Bio-Rad Laboratories Inc Business Overview
 Table 58. Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Product
 Table 59. Bio-Rad Laboratories Inc Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 60. Bio-Rad Laboratories Inc Recent Development
 Table 61. BD Company Details
 Table 62. BD Business Overview
 Table 63. BD OTC and DTC Infectious Disease Diagnostic Product
 Table 64. BD Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 65. BD Recent Development
 Table 66. Bosch Healthcare Solutions GmbH Company Details
 Table 67. Bosch Healthcare Solutions GmbH Business Overview
 Table 68. Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Product
 Table 69. Bosch Healthcare Solutions GmbH Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 70. Bosch Healthcare Solutions GmbH Recent Development
 Table 71. Danaher Company Details
 Table 72. Danaher Business Overview
 Table 73. Danaher OTC and DTC Infectious Disease Diagnostic Product
 Table 74. Danaher Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 75. Danaher Recent Development
 Table 76. ThermoFisher Scientific Company Details
 Table 77. ThermoFisher Scientific Business Overview
 Table 78. ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Product
 Table 79. ThermoFisher Scientific Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 80. ThermoFisher Scientific Recent Development
 Table 81. Siemens AG Company Details
 Table 82. Siemens AG Business Overview
 Table 83. Siemens AG OTC and DTC Infectious Disease Diagnostic Product
 Table 84. Siemens AG Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 85. Siemens AG Recent Development
 Table 86. Roche Holding AG Company Details
 Table 87. Roche Holding AG Business Overview
 Table 88. Roche Holding AG OTC and DTC Infectious Disease Diagnostic Product
 Table 89. Roche Holding AG Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 90. Roche Holding AG Recent Development
 Table 91. Hologic, Inc. Company Details
 Table 92. Hologic, Inc. Business Overview
 Table 93. Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Product
 Table 94. Hologic, Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 95. Hologic, Inc. Recent Development
 Table 96. Qiagen Company Details
 Table 97. Qiagen Business Overview
 Table 98. Qiagen OTC and DTC Infectious Disease Diagnostic Product
 Table 99. Qiagen Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 100. Qiagen Recent Development
 Table 101. Cardinal Health Company Details
 Table 102. Cardinal Health Business Overview
 Table 103. Cardinal Health OTC and DTC Infectious Disease Diagnostic Product
 Table 104. Cardinal Health Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 105. Cardinal Health Recent Development
 Table 106. Quest Diagnostics Incorporated Company Details
 Table 107. Quest Diagnostics Incorporated Business Overview
 Table 108. Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Product
 Table 109. Quest Diagnostics Incorporated Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 110. Quest Diagnostics Incorporated Recent Development
 Table 111. Ador Diagnostics Company Details
 Table 112. Ador Diagnostics Business Overview
 Table 113. Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Product
 Table 114. Ador Diagnostics Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 115. Ador Diagnostics Recent Development
 Table 116. Akonni Biosystems, Inc. Company Details
 Table 117. Akonni Biosystems, Inc. Business Overview
 Table 118. Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Product
 Table 119. Akonni Biosystems, Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 120. Akonni Biosystems, Inc. Recent Development
 Table 121. Alveo Technologies Company Details
 Table 122. Alveo Technologies Business Overview
 Table 123. Alveo Technologies OTC and DTC Infectious Disease Diagnostic Product
 Table 124. Alveo Technologies Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 125. Alveo Technologies Recent Development
 Table 126. Binx Health Inc. Company Details
 Table 127. Binx Health Inc. Business Overview
 Table 128. Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Product
 Table 129. Binx Health Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 130. Binx Health Inc. Recent Development
 Table 131. bioMérieux, Inc. Company Details
 Table 132. bioMérieux, Inc. Business Overview
 Table 133. bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Product
 Table 134. bioMérieux, Inc. Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 135. bioMérieux, Inc. Recent Development
 Table 136. Curetis Company Details
 Table 137. Curetis Business Overview
 Table 138. Curetis OTC and DTC Infectious Disease Diagnostic Product
 Table 139. Curetis Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 140. Curetis Recent Development
 Table 141. Sysmex Europe GmbH Company Details
 Table 142. Sysmex Europe GmbH Business Overview
 Table 143. Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Product
 Table 144. Sysmex Europe GmbH Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 145. Sysmex Europe GmbH Recent Development
 Table 146. Diasorin S.p.A Company Details
 Table 147. Diasorin S.p.A Business Overview
 Table 148. Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Product
 Table 149. Diasorin S.p.A Revenue in OTC and DTC Infectious Disease Diagnostic Business (2020-2025) & (US$ Million)
 Table 150. Diasorin S.p.A Recent Development
 Table 151. Research Programs/Design for This Report
 Table 152. Key Data Information from Secondary Sources
 Table 153. Key Data Information from Primary Sources
 Table 154. Authors List of This Report


List of Figures
 Figure 1. OTC and DTC Infectious Disease Diagnostic Picture
 Figure 2. Global OTC and DTC Infectious Disease Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global OTC and DTC Infectious Disease Diagnostic Market Share by Type: 2024 VS 2031
 Figure 4. PCR Features
 Figure 5. Immunodiagnostics Features
 Figure 6. Clinical Microbiology Features
 Figure 7. INAAT Features
 Figure 8. DNA Sequencing and NGS Features
 Figure 9. DNA Microarrays Features
 Figure 10. Others Features
 Figure 11. Global OTC and DTC Infectious Disease Diagnostic Market Size by Application (2020-2031) & (US$ Million)
 Figure 12. Global OTC and DTC Infectious Disease Diagnostic Market Share by Application: 2024 VS 2031
 Figure 13. Diagnostic Laboratories Case Studies
 Figure 14. Hospitals and Clinics Case Studies
 Figure 15. Academic Research Institutes Case Studies
 Figure 16. Others Case Studies
 Figure 17. OTC and DTC Infectious Disease Diagnostic Report Years Considered
 Figure 18. Global OTC and DTC Infectious Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global OTC and DTC Infectious Disease Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global OTC and DTC Infectious Disease Diagnostic Market Share by Region: 2024 VS 2031
 Figure 21. Global OTC and DTC Infectious Disease Diagnostic Market Share by Players in 2024
 Figure 22. Global Top OTC and DTC Infectious Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC and DTC Infectious Disease Diagnostic as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by OTC and DTC Infectious Disease Diagnostic Revenue in 2024
 Figure 24. North America OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America OTC and DTC Infectious Disease Diagnostic Market Share by Country (2020-2031)
 Figure 26. United States OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe OTC and DTC Infectious Disease Diagnostic Market Share by Country (2020-2031)
 Figure 30. Germany OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific OTC and DTC Infectious Disease Diagnostic Market Share by Region (2020-2031)
 Figure 38. China OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America OTC and DTC Infectious Disease Diagnostic Market Share by Country (2020-2031)
 Figure 46. Mexico OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa OTC and DTC Infectious Disease Diagnostic Market Share by Country (2020-2031)
 Figure 50. Turkey OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE OTC and DTC Infectious Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Abbott Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 54. Bio-Rad Laboratories Inc Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 55. BD Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 56. Bosch Healthcare Solutions GmbH Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 57. Danaher Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 58. ThermoFisher Scientific Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 59. Siemens AG Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 60. Roche Holding AG Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 61. Hologic, Inc. Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 62. Qiagen Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 63. Cardinal Health Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 64. Quest Diagnostics Incorporated Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 65. Ador Diagnostics Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 66. Akonni Biosystems, Inc. Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 67. Alveo Technologies Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 68. Binx Health Inc. Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 69. bioMérieux, Inc. Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 70. Curetis Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 71. Sysmex Europe GmbH Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 72. Diasorin S.p.A Revenue Growth Rate in OTC and DTC Infectious Disease Diagnostic Business (2020-2025)
 Figure 73. Bottom-up and Top-down Approaches for This Report
 Figure 74. Data Triangulation
 Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

GMP Laboratory Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Infectious Disease Diagnostics Market Insights Forecast to 2030
Global Molecular Quality Controls Market Insights Forecast to 2030
Global HIV Diagnostic Test Market Insights Forecast to 2030
Global Pharmaceutical Release Testing Market Research Report 2025
Global DTC Testing Market Insights Forecast to 2030
Global Infectious Diseases Diagnostic Market Insights Forecast to 2030
Global Infection Prevention Products Market Insights Forecast to 2030
Pharmaceutical Sterility Testing Market
Global Infectious Disease Diagnosis Market Insights Forecast to 2030
GMP Cell Banking Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Infectious Disease Test Kit Market Research Report 2024
Global GMP Peptides Market Research Report 2024
Global OTC Tests Market Insights Forecast to 2030
OTC Diet Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Testing Inspection And Certification TIC For Consumer Products Market Insights Forecast to 2030
Infectious Disease Diagnostic Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
OTC Consumer Healthcare Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In Vitro Diagnostics IVD Quality Control Product Market Insights Forecast to 2030
Global HIV Diagnostic Kit Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions